PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

UKRI awards £41m to enhance UK research and innovation

The scheme will help ten projects establish research and innovation clusters.

The UK Research and Innovation’s (UKRI) Engineering and Physical Science’s Research Council (EPSRC) has awarded ten new projects a total of £41m to enhance UK research and innovation.

Over the next four years, the new Place Based Impact Acceleration Account (PBIAA) scheme will combine the UK’s leading engineering and physical science research to help established research and innovation clusters expand and help to develop emerging clusters.

The projects will provide long- and short-term benefits to regional and local economies and communities, including new jobs, skill development, private investment and the growth of small and medium enterprises.

Alongside the EPSRC’s funding, an additional £7.8m has been committed by project partners.

An investment of £4.9m will go towards ‘the industrial biotechnology innovation cluster project’, led by the University of Manchester.

The project will apply cross-disciplinary technologies that use biological resources for producing and processing products, including food, fuels and medicines, to meet urgent societal needs.

The PBIAA will stimulate £2.5m in cash and £4m in-kind co-investment, establish 150 collaborative projects, train over 200 students to take on careers in the biotechnology industry and establish more than 20 new commercial ventures.

Additionally, a further £5m will go towards the University of Leeds’s ‘innovating medical technologies across the Yorkshire region’ project to support university research in medical technologies.

Science minister George Freeman said: “The UK is already home to clusters of world-class science and technology talent, bringing together top universities, cutting-edge research institutes and enterprising businesses of all sizes and it is crucial we channel these hubs of scientific advance and growth to level up our country.

“Our £41m investment will help enhance these clusters’s vast potential for the good of our local economies and the wider country.”

The projects will begin either at the end of 2023 or the beginning of 2024 and the second round of EPSRC’s PBIAA scheme will launch in late October 2023.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026